Together-Breast Cancer Support Platform for Korean-Speaking Patients

This study is testing an online peer-support program called "Together-Breast Cancer Support Platform" for Korean-speaking breast cancer patients and survivors. The goal is to see if this culturally tailored program is acceptable and if people will use it regularly. Researchers also want to find out if participating in the program can improve your quality of life, mental well-being (like reducing anxiety and depression), and feelings of social support. You could join if you are a Korean-speaking woman, at least 18 years old, and have breast cancer. The study will be considered successful if mentors and mentees engage with the platform over 12 weeks. The current recruitment status is unclear.

Study design
This is an observational study involving 24 participants, including 8 mentors (survivors) and 16 mentees (patients). Participants will be matched based on information like age and cancer stage.
What's involved
You would engage in peer-support interactions through an online platform for 12 weeks, with an expectation of at least one interaction per week. Mentors will also complete a structured training program.
Compensation
Not stated in the trial record.
Follow-up
Participants will engage in the program for 12 weeks, which is when the primary outcome of engagement is measured.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07499089

Together-Breast Cancer Support Platform

Not Yet Recruiting
Not specifiedAges 18+Observational
Cedars-Sinai Medical Center
~24 participants
Updated 2026-03-30 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of peer-support platform engagement
Measured over Week 1 to Week 12
Breast Cancer
Breast Cancer Survivors
1 sites across 1 states
California1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years
Self-identify as Korean
Able to read, write, and speak both Korean and English
Diagnosed with breast cancer ≥ 2 years prior to enrollment
Completed active treatment or currently on long-term maintenance therapy
Access to a smartphone, computer, or similar device compatible with the study platform
Willing to participate for at least 3 months
Willing to complete required training and surveys
Age ≥ 18 years
Self-identify as Korean
Able to read, write, and speak Korean
Diagnosed with breast cancer
Currently receiving treatment (e.g., chemotherapy, radiation therapy, recent surgery, or endocrine therapy)
Access to a smartphone, computer, or similar device compatible with the study platform
Willing to participate for at least 3 months
Willing to complete required surveys
Individuals unable to use the online platform or required technology
Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures)
Mentees diagnosed with ductal carcinoma in situ (DCIS)
  • Feasibility of peer-support platform engagementWeek 1 to Week 12

    Feasibility is defined as the proportion of mentor-mentee pairs achieving at least one bidirectional interaction per week for at least 8 out of 12 weeks during the study period.